Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
University of Houston28d
Admissions for PhD Programs
Applicants to the Ph.D. program Concentrations in Medicinal Chemistry, Pharmaceutics and Pharmacology must have ... The average GPA of students admitted in 2018 and 2019 was 3.6. A GRE score is ...